LQDA: Liquidia Corporation Stock

by  •  • Comments Off on LQDA: Liquidia Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,032.46
Enterprise Value ($M) 994.81
Book Value ($M) 47.29
Book Value / Share 0.62
Price / Book 21.83
NCAV ($M) 18.86
NCAV / Share 0.25
Price / NCAV 54.74

Profitability (mra)
Return on Invested Capital (ROIC) -0.81
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.87

Liquidity (mrq)
Quick Ratio 4.85
Current Ratio 4.85

Balance Sheet (mrq) ($M)
Current Assets 89.90
Assets 118.33
Liabilities 71.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 17.49
Operating Income -73.38
Net Income -78.50

Cash Flow Statement (mra) ($M)
Cash From Operations -41.56
Cash from Investing -11.29
Cash from Financing 43.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Manning Paul B 9.20 5.06
02-07 13G/A BlackRock Inc. 4.97 -3.33
01-16 13G Legend Aggregator, LP 9.50
12-14 13D/A Caligan Partners LP 15.30 44.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-17 130,134 608,710 21.38
2024-04-16 86,519 420,358 20.58
2024-04-15 94,227 499,781 18.85
2024-04-12 250,521 472,096 53.07

(click for more detail)

Similar Companies
LIXT – Lixte Biotechnology Holdings, Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc. LSDI – Lucy Scientific Discovery Inc.
LSTA – Lisata Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io